Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific doses and precautions.
February 2026 in “Scientific Messenger of LNU of Veterinary Medicine and Biotechnology” Dermatophytosis in cats is treated with antifungal medications.
February 2026 in “Expert Opinion on Pharmacotherapy” Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific dosing and timing guidelines.
February 2026 in “Journal of Drugs in Dermatology” Dupilumab helped a 13-year-old regrow hair after alopecia totalis.
January 2026 in “SKIN The Journal of Cutaneous Medicine” Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.
January 2026 in “Indian Journal of Dermatopathology and Diagnostic Dermatology” Corkscrew hairs can help diagnose trichotillomania.
November 2025 in “Сибирский научный медицинский журнал” TS-13 speeds up hair regrowth after chemotherapy.
October 2025 in “EMJ Dermatology” GLP-1RA therapy may increase the risk of hair loss.
October 2025 in “Frontiers in Endocrinology” Methimazole for hyperthyroidism has known and new side effects needing more study for safety.
September 2025 in “SKIN The Journal of Cutaneous Medicine” Isotretinoin can cause hair loss, and reducing the dose or using supplements like vitamin D and iron may help.
September 2025 in “Journal of the American Academy of Dermatology” Both 2.5 mg and 5 mg doses of oral minoxidil are effective for hair regrowth in men with hair loss.
September 2025 in “Therapies” Finasteride use for hair loss may cause depression and suicidal thoughts, requiring careful monitoring.
August 2025 in “International Journal of Cancer” Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.
August 2025 in “Clinical and Experimental Dermatology” Alopecia areata treatments often don't lead to lasting improvement.
Dupilumab may cause hair loss, so patients should be monitored.
July 2025 in “Journal of Investigative Dermatology” Nelfb is essential for dermal fat development and survival.
June 2025 in “British Journal of Dermatology” Dupilumab can cause psoriasis in some patients.
June 2025 in “BMJ Case Reports” Axitinib treatment turned a man's grey hair back to black.
Microneedling may improve neck scars, but more research is needed.
May 2025 in “International Journal of Trichology” Low-dose oral minoxidil often causes excess hair growth but doesn't significantly affect quality of life.
Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.
March 2025 in “Dermatology” Systemic therapies improve nail psoriasis but have high side effects; more research is needed.
February 2025 in “Journal of Dermatological Treatment” Low-dose oral minoxidil improved hair growth in a woman with short anagen syndrome.
January 2025 in “Farmaciâ Kazahstana” Androgenetic alopecia is more common in men and varies by population, with treatments explored in the review.
January 2025 in “Catalysts” High-temperature gelatinization of ginkgo seeds effectively increases β-cyclodextrin production.
January 2025 in “Open Life Sciences” Overexpression of the HE4 gene in mice causes eye inflammation and cloudiness.
December 2024 in “Indian Journal of Dermatology” Dermoscopy is useful for diagnosing Atrichia with Papular Lesions in children without needing a biopsy.
October 2024 in “Journal of the Endocrine Society” Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.
Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.